Evidence map›Paper›PMID 22666515›Full record

ArticlePLoS neglected tropical diseases2012

The Sigma class glutathione transferase from the liver fluke Fasciola hepatica.

E James LaCourse, Samirah Perally, Russell M Morphew, Joseph V Moxon, Mark Prescott, David J Dowling, Sandra M O'Neill, Anja Kipar, Udo Hetzel, Elizabeth Hoey and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Assessment of oxidative stress biomarkers in liver flukeVeterinary research forum : an international quarterly journal · 2026
    Article
  3. Article
  4. Detoxome Capacity of the Adult Rumen FlukeJournal of proteome research · 2025
    Article
  5. Pathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Microbiology spectrum · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

E James LaCourseInstitute of Biological, Environmental and Rural Sciences, Aberystwyth University, Aberystwyth, Wales, UK.
Samirah Perally
Russell M Morphew
Joseph V Moxon
Mark Prescott
David J Dowling
Sandra M O'Neill
Anja Kipar
Udo Hetzel
Elizabeth Hoey
Rafael Zafra
Leandro Buffoni
José Pérez Arévalo
Peter M Brophy
University of Córdoba · ESUniversity of Liverpool · GBAberystwyth University · GBDublin City University · IEInstitute of Biological, Environmental and Rural Sciences · GBLiverpool School of Tropical Medicine · GBQueen's University Belfast · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C503638/2Biotechnology and Biological Sciences Research Council BB/H009256/1Biotechnology and Biological Sciences Research Council BB/H009477/1
6 · The paper itself

Abstract

backgroundLiver fluke infection of livestock causes economic losses of over US$ 3 billion worldwide per annum. The disease is increasing in livestock worldwide and is a re-emerging human disease. There are currently no commercial vaccines, and only one drug with significant efficacy against adult worms and juveniles. A liver fluke vaccine is deemed essential as short-lived chemotherapy, which is prone to resistance, is an unsustainable option in both developed and developing countries. Protein superfamilies have provided a number of leading liver fluke vaccine candidates. A new form of glutathione transferase (GST) family, Sigma class GST, closely related to a leading Schistosome vaccine candidate (Sm28), has previously been revealed by proteomics in the liver fluke but not functionally characterised. METHODOLOGY/PRINCIPAL

findingsIn this manuscript we show that a purified recombinant form of the F. hepatica Sigma class GST possesses prostaglandin synthase activity and influences activity of host immune cells. Immunocytochemistry and western blotting have shown the protein is present near the surface of the fluke and expressed in eggs and newly excysted juveniles, and present in the excretory/secretory fraction of adults. We have assessed the potential to use F. hepatica Sigma class GST as a vaccine in a goat-based vaccine trial. No significant reduction of worm burden was found but we show significant reduction in the pathology normally associated with liver fluke infection. CONCLUSIONS/SIGNIFICANCE: We have shown that F. hepatica Sigma class GST has likely multi-functional roles in the host-parasite interaction from general detoxification and bile acid sequestration to PGD synthase activity.

Indexed as

AnimalsAntigens, HelminthBlotting, WesternDisease Models, AnimalFasciola hepaticaFascioliasisGene Expression ProfilingGlutathione TransferaseGoatsImmunohistochemistryMiceMice, Inbred C57BLParasite LoadProstaglandin-Endoperoxide SynthasesRecombinant ProteinsVaccinationAntigens, HelminthGlutathione TransferaseProstaglandin-Endoperoxide SynthasesRecombinant ProteinsVaccines, Synthetic

Identifiers

PMID22666515
PMCPMC3362645
OpenAlexW1971661217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.